Site icon Impactiviti

Game-changing Drugs

This week, Novartis got U.S. approval for Reclast, a once-yearly treatment for osteoporosis. A fifteen minute infusion, once a year – talk about convenience and better patient compliance!

Very cool. A lot of drugs are incremental improvements, or similar to others in the same class. These game-changers are exciting.

Exit mobile version